In The Press

“Khosla Ventures leads $38M seed round for organoid startup Vivodyne”

Endpoints
•
Nov 22, 2023
Share on

Discover More Articles

view all posts
Vivodyne Appoints Elliot Menschik as Chief Technology Officer
"One founder is using lab-grown human organs in combination with AI to test drug efficacy."
“Vivodyne plants seed funds to grow engineered human tissue platform”
"[Vivodyne] is solving the biggest problem to creating drugs that work"
“This startup raised $38 million to fill one of the biggest gaps in drug discovery”
Human data before the clinic.
Connect With Us
Applications
Philadelphia, USA
© 2024 Vivodyne
Privacy
linkedinlinkedinxx